Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Genomic tools development for Aquilegia: construction of a BAC-based physical map.

Fang GC, Blackmon BP, Henry DC, Staton ME, Saski CA, Hodges SA, Tomkins JP, Luo H.

BMC Genomics. 2010 Nov 8;11:621. doi: 10.1186/1471-2164-11-621.

2.

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years.

GlaxoSmithKline Vaccine HPV-007 Study Group, Romanowski B, de Borba PC, Naud PS, Roteli-Martins CM, De Carvalho NS, Teixeira JC, Aoki F, Ramjattan B, Shier RM, Somani R, Barbier S, Blatter MM, Chambers C, Ferris D, Gall SA, Guerra FA, Harper DM, Hedrick JA, Henry DC, Korn AP, Kroll R, Moscicki AB, Rosenfeld WD, Sullivan BJ, Thoming CS, Tyring SK, Wheeler CM, Dubin G, Schuind A, Zahaf T, Greenacre M, Sgriobhadair A.

Lancet. 2009 Dec 12;374(9706):1975-85. doi: 10.1016/S0140-6736(09)61567-1. Epub .

PMID:
19962185
3.

Polyacidic multiloading metal extractants.

Gordon RJ, Campbell J, Henderson DK, Henry DC, Swart RM, Tasker PA, White FJ, Wood JL, Yellowlees LJ.

Chem Commun (Camb). 2008 Oct 21;(39):4801-3. doi: 10.1039/b810610j. Epub 2008 Aug 22.

PMID:
18830498
4.

A blackberry (Rubus L.) expressed sequence tag library for the development of simple sequence repeat markers.

Lewers KS, Saski CA, Cuthbertson BJ, Henry DC, Staton ME, Main DS, Dhanaraj AL, Rowland LJ, Tomkins JP.

BMC Plant Biol. 2008 Jun 20;8:69. doi: 10.1186/1471-2229-8-69.

5.

Straw blood cell count, growth, inhibition and comparison to apoptotic bodies.

Wu Y, Henry DC, Heim K, Tomkins JP, Kuan CY.

BMC Cell Biol. 2008 May 20;9:26. doi: 10.1186/1471-2121-9-26.

6.

Naturally occurring and stress induced tubular structures from mammalian cells, a survival mechanism.

Wu Y, Laughlin RC, Henry DC, Krueger DE, Hudson JS, Kuan CY, He J, Reppert J, Tomkins JP.

BMC Cell Biol. 2007 Aug 16;8:36.

7.

The assembly of rotaxane-like dye/cyclodextrin/surface complexes on aluminium trihydroxide or goethite.

Cooper RJ, Camp PJ, Gordon RJ, Henderson DK, Henry DC, McNab H, De Silva SS, Tackley D, Tasker PA, Wight P.

Dalton Trans. 2006 Jun 21;(23):2785-93. Epub 2006 May 5.

PMID:
16751886
8.
9.

Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa.

Roland PS, Pien FD, Schultz CC, Henry DC, Conroy PJ, Wall GM, Garadi R, Dupre SJ, Potts SL, Hogg LG, Stroman DW; Ciprodex Otic AOE Study Group.

Curr Med Res Opin. 2004 Aug;20(8):1175-83.

PMID:
15324520
10.
11.

Attachment of phosphonate-functionalised azo-dyes to oxide surfaces to give enhanced light and wet fastness.

De Silva SS, Camp PJ, Henderson DK, Henry DC, McNab H, Tasker PA, Wight P.

Chem Commun (Camb). 2003 Jul 21;(14):1702-3.

PMID:
12877511
12.

Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women.

Henry DC Jr, Bettis RB, Riffer E, Haverstock DC, Kowalsky SF, Manning K, Hamed KA, Church DA.

Clin Ther. 2002 Dec;24(12):2088-104.

PMID:
12581547
13.

Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis.

Henry DC, Sydnor A Jr, Settipane GA, Allen J, Burroughs S, Cobb MM, Holley HP Jr.

Clin Ther. 1999 Jul;21(7):1158-70.

PMID:
10463514
14.
15.

Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.

Lipsky BA, Miller B, Schwartz R, Henry DC, Nolan T, McCabe A, Magner DJ, Talbot GH.

Clin Ther. 1999 Apr;21(4):675-90.

PMID:
10363733
16.

Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study Group.

Henry DC, Moller DJ Jr, Adelglass J, Scheld WM, Jablonski CK, Zhang H, Talbot GH.

Clin Ther. 1999 Feb;21(2):340-52.

PMID:
10211537
17.

Five-day cefdinir treatment for streptococcal pharyngitis. Cefdinir Pharyngitis Study Group.

Tack KJ, Henry DC, Gooch WM, Brink DN, Keyserling CH.

Antimicrob Agents Chemother. 1998 May;42(5):1073-5.

18.

Gastric morphological changes including carcinoid tumors in animals treated with a potent hypolipidemic agent, ciprofibrate.

Spencer AJ, Barbolt TA, Henry DC, Eason CT, Sauerschell RJ, Bonner FW.

Toxicol Pathol. 1989;17(1 Pt 1):7-15.

19.

Species variation in gastric toxicity following chronic administration of ciprofibrate to rat, mouse, and marmoset.

Eason CT, Spencer AJ, Pattison A, Howells DD, Henry DC, Bonner FW.

Toxicol Appl Pharmacol. 1988 Sep 15;95(2):328-38.

PMID:
3138789
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk